Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001596771-18-000019)

Filing Details

Accession Number:: 0001596771-18-000019
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-02-12 16:31:00
Reporting Period:: 2018-02-08

Accepted Time:: 2018-02-12 16:31:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1638287	Gemphire Therapeutics Inc.	GEMP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1571997	Ph.d. R. Steven Gullans	17199 N. Laurel Park Drive Suite 401 Livonia MI 48152	Interim President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-02-08	71,429	$7.00	930,252	No	4	P	Indirect	Held by Excel Venture Fund II, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Held by Excel Venture Fund II, L.P.

Footnotes

The shares were purchased in a confidentially marketed public offering pursuant to an Underwriting Agreement. The offering closed on February 12, 2018.
The reporting person, as the Manager of Excel Venture Fund II, L.P., beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.